Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Difficult to manage but essential for success

被引：12

作者：

Samuel, Didier ^{[1
]}

Roche, Bruno

机构：

[1] INSERM, Unite 785, F-94804 Villejuif, France

[2] Univ Paris Sud, UMR S785, F-94804 Villejuif, France

[3] Hop Paul Brousse, Ctr Hepatobiliaire, AP HP, Villejuif, France

来源：

JOURNAL OF HEPATOLOGY | 2007年 / 46卷 / 06期

关键词：

D O I：

10.1016/j.jhep.2007.03.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：988 / 991

页数：4

共 30 条

[1] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C [J].

Angelico, Mario ;

Petrolati, Alessandra ;

Lionetti, Raffaella ;

Lenci, Ilaria ;

Burra, Patrizia ;

Donato, Maria Francesca ;

Merli, Manuela ;

Strazzabosco, Mario ;

Tisone, Giuseppe .

JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1009-1017

[2] Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].

Berenguer, M ;

Prieto, M ;

Rayón, JM ;

Mora, J ;

Pastor, M ;

Ortiz, V ;

Carrasco, D ;

San Juan, F ;

Burgueño, MDJ ;

Mir, J ;

Berenguer, J .

HEPATOLOGY, 2000, 32 (04) :852-858

[3] Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].

Berenguer, M ;

Prieto, M ;

San Juan, F ;

Rayón, JM ;

Martinez, F ;

Carrasco, D ;

Moya, A ;

Orbis, F ;

Mir, J ;

Berenguer, J .

HEPATOLOGY, 2002, 36 (01) :202-210

[4] HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].

Berenguer, M ;

Ferrell, L ;

Watson, J ;

Prieto, M ;

Kim, M ;

Rayón, M ;

Córdoba, J ;

Herola, A ;

Ascher, N ;

Mir, J ;

Berenguer, J ;

Wright, TL .

JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684

[5] Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence [J].

Bizollon, T ;

Ahmed, SNS ;

Radenne, S ;

Chevallier, M ;

Chevallier, P ;

Parvaz, P ;

Guichard, S ;

Ducerf, C ;

Baulieux, J ;

Zoulim, F ;

Trepo, C .

GUT, 2003, 52 (02) :283-287

[6] Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C [J].

Bizollon, T ;

Pradat, P ;

Mabrut, JY ;

Chevallier, M ;

Adham, M ;

Radenne, S ;

Souquet, JC ;

Ducerf, C ;

Baulieux, J ;

Zoulim, F ;

Trepo, C .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (08) :1909-1913

[7] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].

Bizollon, T ;

Palazzo, U ;

Ducerf, C ;

Chevallier, M ;

Elliott, M ;

Baulieux, J ;

Pouyet, M ;

Trepo, C .

HEPATOLOGY, 1997, 26 (02) :500-504

[8] Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation [J].

Blasco, A ;

Forns, X ;

Carrión, JA ;

García-Pagán, JC ;

Gilbert, R ;

Rimola, A ;

Nbquel, R ;

Bruguera, M ;

García-Valdecasas, JC ;

Bosch, J ;

Navasa, M .

HEPATOLOGY, 2006, 43 (03) :492-499

[9] Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation [J].

Castells, L ;

Vargas, V ;

Allende, H ;

Bilbao, I ;

Lázaro, JL ;

Margarit, C ;

Esteban, R ;

Guardia, J .

JOURNAL OF HEPATOLOGY, 2005, 43 (01) :53-59

[10] Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials [J].

Chalasani, N ;

Manzarbeitia, C ;

Ferenci, P ;

Vogel, W ;

Fontana, RJ ;

Voigt, M ;

Riely, C ;

Martin, P ;

Teperman, L ;

Jiao, J ;

Lopez-Talavera, JC .

HEPATOLOGY, 2005, 41 (02) :289-298

← 1 2 3 →